| cellular amino acid metabolic process | GO:0006520 | 103 | 0.270 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.263 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.194 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.188 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.139 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.119 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.116 | |
| cation transport | GO:0006812 | 399 | 0.112 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.110 | |
| cation homeostasis | GO:0055080 | 212 | 0.107 | |
| male gamete generation | GO:0048232 | 285 | 0.106 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.091 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.084 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.080 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.078 | |
| cellular homeostasis | GO:0019725 | 240 | 0.076 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.076 | |
| regulation of binding | GO:0051098 | 111 | 0.075 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.072 | Mouse |
| cellular ion homeostasis | GO:0006873 | 165 | 0.071 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.068 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.068 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.068 | |
| regulation of ion transport | GO:0043269 | 215 | 0.068 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.068 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.065 | |
| regulation of cell activation | GO:0050865 | 289 | 0.065 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.064 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.063 | |
| membrane organization | GO:0061024 | 245 | 0.062 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.061 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.060 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.059 | |
| gonad development | GO:0008406 | 141 | 0.058 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.058 | |
| vesicle organization | GO:0016050 | 60 | 0.057 | |
| oxidation reduction process | GO:0055114 | 342 | 0.057 | |
| maintenance of location | GO:0051235 | 89 | 0.056 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.056 | |
| positive regulation of necrotic cell death | GO:0010940 | 1 | 0.056 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.054 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.053 | |
| protein maturation | GO:0051604 | 176 | 0.052 | |
| endocytosis | GO:0006897 | 168 | 0.051 | |
| response to amino acid | GO:0043200 | 37 | 0.050 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.050 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.050 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.050 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.050 | |
| amine metabolic process | GO:0009308 | 45 | 0.049 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.048 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.048 | |
| protein import into nucleus | GO:0006606 | 95 | 0.048 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.048 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.046 | |
| response to inorganic substance | GO:0010035 | 96 | 0.046 | |
| protein catabolic process | GO:0030163 | 221 | 0.046 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.046 | |
| spermatogenesis | GO:0007283 | 284 | 0.046 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.045 | |
| calcium ion transport | GO:0006816 | 159 | 0.044 | |
| positive regulation of exocytosis | GO:0045921 | 20 | 0.044 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.044 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.044 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.043 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.043 | |
| intracellular protein transport | GO:0006886 | 204 | 0.043 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.043 | |
| regulation of secretion | GO:0051046 | 274 | 0.042 | |
| ubiquitin dependent protein catabolic process via the multivesicular body sorting pathway | GO:0043162 | 3 | 0.041 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.040 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.040 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.040 | |
| golgi vesicle transport | GO:0048193 | 30 | 0.040 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.039 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.038 | |
| regulation of protein localization | GO:0032880 | 231 | 0.038 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.038 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.038 | |
| wound healing | GO:0042060 | 157 | 0.038 | |
| dna metabolic process | GO:0006259 | 303 | 0.038 | |
| granzyme mediated apoptotic signaling pathway | GO:0008626 | 1 | 0.037 | |
| tissue homeostasis | GO:0001894 | 115 | 0.037 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.037 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.037 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.037 | |
| t cell activation | GO:0042110 | 289 | 0.036 | |
| protein localization to organelle | GO:0033365 | 185 | 0.036 | |
| regulation of protein stability | GO:0031647 | 52 | 0.036 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.035 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.034 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.033 | |
| innate immune response | GO:0045087 | 157 | 0.033 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.033 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.033 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.033 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.033 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.032 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.032 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.032 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.032 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.032 | |
| maternal placenta development | GO:0001893 | 20 | 0.031 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.031 | |
| arp2 3 complex mediated actin nucleation | GO:0034314 | 3 | 0.031 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.031 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.031 | |
| response to oxidative stress | GO:0006979 | 123 | 0.031 | Yeast |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.030 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.030 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.030 | |
| extracellular structure organization | GO:0043062 | 148 | 0.030 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.030 | |
| necrotic cell death | GO:0070265 | 30 | 0.030 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.030 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.030 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.029 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.029 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.029 | |
| cell killing | GO:0001906 | 67 | 0.029 | |
| nuclear division | GO:0000280 | 158 | 0.028 | |
| immune effector process | GO:0002252 | 321 | 0.028 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.028 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.028 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.028 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.028 | |
| transmembrane transport | GO:0055085 | 412 | 0.028 | |
| epidermis development | GO:0008544 | 187 | 0.027 | |
| nuclear import | GO:0051170 | 95 | 0.027 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.027 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.027 | |
| renal system development | GO:0072001 | 225 | 0.027 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.027 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.026 | |
| regulation of defense response | GO:0031347 | 233 | 0.026 | |
| skin development | GO:0043588 | 220 | 0.026 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.026 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.026 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.026 | |
| t cell differentiation | GO:0030217 | 174 | 0.025 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.025 | |
| mapk cascade | GO:0000165 | 281 | 0.025 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.025 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.025 | |
| regulation of protein transport | GO:0051223 | 163 | 0.025 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.025 | |
| mesonephros development | GO:0001823 | 97 | 0.025 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.025 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.025 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.025 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.025 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.025 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.025 | |
| nuclear transport | GO:0051169 | 139 | 0.025 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.025 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.024 | |
| kidney development | GO:0001822 | 213 | 0.024 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.024 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.024 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.024 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.024 | |
| hydrogen ion transmembrane transport | GO:1902600 | 25 | 0.024 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.023 | |
| regulation of arp2 3 complex mediated actin nucleation | GO:0034315 | 1 | 0.023 | |
| endomembrane system organization | GO:0010256 | 147 | 0.023 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.023 | |
| cell fate commitment | GO:0045165 | 210 | 0.023 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.023 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.023 | |
| ketone catabolic process | GO:0042182 | 3 | 0.022 | Mouse |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.022 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.022 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.022 | Yeast |
| hemostasis | GO:0007599 | 78 | 0.022 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.022 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.022 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.022 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.022 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.022 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.021 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.021 | |
| actin filament branching | GO:0090135 | 1 | 0.021 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.021 | |
| inter male aggressive behavior | GO:0002121 | 3 | 0.021 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.020 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.020 | |
| gland development | GO:0048732 | 330 | 0.020 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.020 | Mouse |
| response to organic cyclic compound | GO:0014070 | 198 | 0.020 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.020 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.020 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.020 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.020 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.020 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 45 | 0.020 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.020 | |
| blood coagulation | GO:0007596 | 76 | 0.020 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.019 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.019 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.019 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.019 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.019 | |
| camera type eye development | GO:0043010 | 266 | 0.019 | |
| heart morphogenesis | GO:0003007 | 178 | 0.019 | |
| positive regulation of actin nucleation | GO:0051127 | 3 | 0.019 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.019 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.019 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.018 | |
| inflammatory response | GO:0006954 | 244 | 0.018 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.018 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.018 | |
| protein processing | GO:0016485 | 163 | 0.018 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.018 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.018 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.018 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.018 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.018 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.018 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.018 | Mouse |
| response to metal ion | GO:0010038 | 47 | 0.018 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.018 | |
| cellular response to thyroid hormone stimulus | GO:0097067 | 1 | 0.018 | |
| natural killer cell activation involved in immune response | GO:0002323 | 10 | 0.017 | |
| regulation of transcription regulatory region dna binding | GO:2000677 | 9 | 0.017 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.017 | |
| er to golgi vesicle mediated transport | GO:0006888 | 11 | 0.017 | |
| actin filament polymerization | GO:0030041 | 44 | 0.017 | |
| positive regulation of lamellipodium assembly | GO:0010592 | 2 | 0.017 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.017 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.017 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.017 | |
| sensory perception | GO:0007600 | 245 | 0.017 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.017 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.017 | |
| natural killer cell degranulation | GO:0043320 | 3 | 0.017 | |
| cellular response to lipid | GO:0071396 | 145 | 0.017 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.017 | |
| protein import | GO:0017038 | 101 | 0.017 | |
| neuronal action potential | GO:0019228 | 54 | 0.017 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.017 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.017 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.016 | |
| skeletal system development | GO:0001501 | 356 | 0.016 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.016 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.016 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.016 | |
| male gonad development | GO:0008584 | 88 | 0.016 | |
| ear morphogenesis | GO:0042471 | 118 | 0.016 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.016 | |
| positive regulation of lamellipodium organization | GO:1902745 | 3 | 0.016 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.016 | |
| protein targeting | GO:0006605 | 143 | 0.016 | |
| microtubule based transport | GO:0010970 | 50 | 0.016 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.016 | |
| protein stabilization | GO:0050821 | 25 | 0.015 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.015 | |
| positive regulation of growth | GO:0045927 | 104 | 0.015 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.015 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.015 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.015 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.015 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.015 | |
| regulation of ossification | GO:0030278 | 112 | 0.015 | |
| peptide transport | GO:0015833 | 133 | 0.014 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.014 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.014 | |
| negative regulation of vesicle fusion | GO:0031339 | 1 | 0.014 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.014 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.014 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.014 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.014 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.014 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.014 | |
| regulation of cell motility | GO:2000145 | 236 | 0.014 | |
| urogenital system development | GO:0001655 | 261 | 0.014 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.014 | |
| positive regulation of mitochondrial calcium ion concentration | GO:0051561 | 3 | 0.014 | |
| sensory system development | GO:0048880 | 3 | 0.014 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.014 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.014 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.014 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.014 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.014 | |
| protein ubiquitination | GO:0016567 | 171 | 0.014 | |
| male sex differentiation | GO:0046661 | 109 | 0.013 | |
| t cell proliferation | GO:0042098 | 120 | 0.013 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.013 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.013 | |
| lipid localization | GO:0010876 | 126 | 0.013 | |
| regulation of cell shape | GO:0008360 | 39 | 0.013 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.013 | |
| multicellular organism growth | GO:0035264 | 161 | 0.013 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.013 | |
| ossification | GO:0001503 | 216 | 0.013 | |
| proton transport | GO:0015992 | 35 | 0.013 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.013 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.013 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.013 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.013 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.013 | |
| protein secretion | GO:0009306 | 111 | 0.013 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.013 | |
| molting cycle | GO:0042303 | 90 | 0.013 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.013 | |
| mechanoreceptor differentiation | GO:0042490 | 67 | 0.013 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.013 | |
| calcium mediated signaling using intracellular calcium source | GO:0035584 | 3 | 0.013 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.013 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.013 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.013 | |
| rna interference | GO:0016246 | 2 | 0.012 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.012 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.012 | |
| response to acid chemical | GO:0001101 | 111 | 0.012 | |
| protein oligomerization | GO:0051259 | 67 | 0.012 | |
| bone development | GO:0060348 | 120 | 0.012 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.012 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.012 | |
| regulation of neuron death | GO:1901214 | 134 | 0.012 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 31 | 0.012 | |
| ceramide biosynthetic process | GO:0046513 | 20 | 0.012 | |
| circulatory system process | GO:0003013 | 197 | 0.012 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.012 | |
| placenta development | GO:0001890 | 140 | 0.012 | |
| amide transport | GO:0042886 | 138 | 0.012 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.012 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.012 | |
| lateral line system development | GO:0048925 | 1 | 0.012 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.012 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.012 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.012 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.012 | |
| lateral inhibition | GO:0046331 | 1 | 0.012 | |
| connective tissue development | GO:0061448 | 179 | 0.012 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.012 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.012 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.012 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.012 | |
| membrane fusion | GO:0061025 | 38 | 0.012 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.012 | |
| fucose metabolic process | GO:0006004 | 1 | 0.011 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.011 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.011 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.011 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.011 | |
| transcription factor import into nucleus | GO:0042991 | 26 | 0.011 | |
| single organism nuclear import | GO:1902593 | 95 | 0.011 | |
| diol metabolic process | GO:0034311 | 5 | 0.011 | |
| tissue remodeling | GO:0048771 | 102 | 0.011 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.011 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.011 | |
| microtubule based process | GO:0007017 | 236 | 0.011 | |
| plasma cell differentiation | GO:0002317 | 3 | 0.011 | |
| regulation of cell migration | GO:0030334 | 219 | 0.011 | |
| axon ensheathment | GO:0008366 | 76 | 0.011 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.011 | |
| lipid storage | GO:0019915 | 36 | 0.011 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.011 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.011 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.011 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.011 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.011 | |
| epithelial cell development | GO:0002064 | 159 | 0.011 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.011 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.011 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.010 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.010 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.010 | |
| notochord cell development | GO:0060035 | 1 | 0.010 | |
| regulation of dna binding | GO:0051101 | 39 | 0.010 | |
| muscle cell fate specification | GO:0042694 | 1 | 0.010 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.010 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.010 | |
| plasma membrane organization | GO:0007009 | 90 | 0.010 | |
| protein polymerization | GO:0051258 | 57 | 0.010 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.010 | |
| bundle of his development | GO:0003166 | 4 | 0.010 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.010 | |
| regulation of coagulation | GO:0050818 | 31 | 0.010 | |
| regulation of transcription factor import into nucleus | GO:0042990 | 24 | 0.010 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.010 | |
| hexose metabolic process | GO:0019318 | 98 | 0.010 | Yeast |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.010 | |
